thumbnail image
  • Home
  • About us  
    • Company
    • CORE TEAM
    • QUALITY UNIT
    • BUSINESS
  • Services  
    • GENERAL TOXICOLOGY
    • DART
    • GENETIC TOXICOLOGY
    • SAFETY PHARMACOLOGY
    • PK/TK
    • EFFICACY STUDY
    • OPHTHALMIC LAB
    • CARCINOGENES
    • Project Management System for Client
  • Laboratories  
    • PATHOLOGY LAB
    • CLINICAL LAB
    • BIO-ANALYSIS
    • TEST ARTICLE LAB
  • Animal Welfare  
    • Animal welfare
  • News&Events
  • Home
  • About us
    • Company
    • CORE TEAM
    • QUALITY UNIT
    • BUSINESS
  • Services
    • GENERAL TOXICOLOGY
    • DART
    • GENETIC TOXICOLOGY
    • SAFETY PHARMACOLOGY
    • PK/TK
    • EFFICACY STUDY
    • OPHTHALMIC LAB
    • CARCINOGENES
    • Project Management System for Client
  • Laboratories
    • PATHOLOGY LAB
    • CLINICAL LAB
    • BIO-ANALYSIS
    • TEST ARTICLE LAB
  • Animal Welfare
    • Animal welfare
  • News&Events
    • CARCINOGENES

       

      Our carcinogenesis study unit has accumulated a good amount of background data and practice experience from conducting 2-year carcinogenic studies for 4 new drugs. Our unit is the first of China to adopt mass tracking module of Pristima v7.0 (a module specifically designed for carcinogenesis study) to achieve real-time, professional and accurate carcinogenesis data collection, tracking and analysis from in vivo tumor.

      SERVICES

      •  Rat long-term carcinogenesis study (2 years)
      • Transgenic mouse short-term carcinogenesis study

       

       

      所有文章
      ×
      成都华西海圻医药科技有限公司(English)
      成都华西海圻医药科技有限公司,国家成都新药安全性评价中心
      https://user-assets.sxlcdn.com/images/397921/Fuuup8iHbnSRXKbrJb7f8RgJ3o2r.png?imageMogr2/strip/auto-orient/thumbnail/1200x630>/format/png
      Cookie的使用
      我们使用cookies来确保流畅的浏览体验。若继续,我们认为你接受使用cookies。
      了解更多